Personal information

Activities

Professional activities (1)

American Association for Cancer Research: Philadelphia, PA, US

2021-12-06 to present | Associate Member
Membership
Source: Self-asserted source
Emma Wilkinson

Works (8)

Targeting DTX2/UFD1-mediated FTO degradation to regulate antitumor immunity

Proceedings of the National Academy of Sciences
2024-12-17 | Journal article
Contributors: Yan-Hong Cui; Jiangbo Wei; Hao Fan; Wenlong Li; Lijie Zhao; Emma Wilkinson; Jack Peterson; Lishi Xie; Zhongyu Zou; Seungwon Yang et al.
Source: check_circle
Crossref

ALKBH4 Stabilization Is Required for Arsenic-Induced 6mA DNA Methylation Inhibition, Keratinocyte Malignant Transformation, and Tumorigenicity

Water
2022-11-08 | Journal article
Contributors: Yan-Hong Cui; Emma Wilkinson; Jack Peterson; Yu-Ying He
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Pharmacogenomics of cisplatin-induced neurotoxicities: Hearing loss, tinnitus, and peripheral sensory neuropathy.

Cancer medicine
2022-03-23 | Journal article
Source: Self-asserted source
Emma Wilkinson

Roles of RNA Modifications in Diverse Cellular Functions.

Frontiers in cell and developmental biology
2022-03-08 | Journal article
Source: Self-asserted source
Emma Wilkinson

Context-Dependent Roles of RNA Modifications in Stress Responses and Diseases

International Journal of Molecular Sciences
2021-02-16 | Journal article
Contributors: Emma Wilkinson; Yan-Hong Cui; Yu-Ying He
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

5-hydroxymethylcytosine profiles in circulating cell-free DNA associate with disease burden in children with neuroblastoma

Clinical Cancer Research
2019-12-18 | Journal article
Part of ISSN: 1078-0432
Part of ISSN: 1557-3265
Source: Self-asserted source
Emma Wilkinson

5-Hydroxymethylcytosine Profiles Are Prognostic of Outcome in Neuroblastoma and Reveal Transcriptional Networks That Correlate With Tumor Phenotype.

JCO precision oncology
2019-05-16 | Journal article
Source: Self-asserted source
Emma Wilkinson

Maternal Embryonic Leucine Zipper Kinase (MELK), a Potential Therapeutic Target for Neuroblastoma.

Molecular cancer therapeutics
2019-01-23 | Journal article
Source: Self-asserted source
Emma Wilkinson